January 2, 2025
Fixed Assets

We’re A Little Worried About Acurx Pharmaceuticals’ (NASDAQ:ACXP) Cash Burn Rate

There’s no doubt that money can be made by owning shares of unprofitable businesses. For example, biotech and mining exploration companies often lose money for years before finding success with a new treatment or mineral discovery. But the harsh reality is that very many loss making companies burn through all their cash and go bankrupt.

Read More
Tangible Assets

Here’s Why We’re Watching Noxopharm’s (ASX:NOX) Cash Burn Situation

There’s no doubt that money can be made by owning shares of unprofitable businesses. Indeed, Noxopharm (ASX:NOX) stock is up 189% in the last year, providing strong gains for shareholders. Nonetheless, only a fool would ignore the risk that a loss making company burns through its cash too quickly. So notwithstanding the buoyant share price,

Read More
Intangible Assets

Overvalued With High Goodwill and Intangible Assets

Marvell Technology Inc. (NASDAQ:MRVL) has experienced significant volatility in the stock market. Over the past three years, its share price has fluctuated widely, ranging from $36 to $89. Recently, it plunged nearly 11.40% following the announcement of first-quarter guidance that fell short of expectations. Despite this recent drop, I believe Marvell remains significantly overvalued. Growing

Read More
Fixed Assets

Here’s Why We’re Not At All Concerned With Intra-Cellular Therapies’ (NASDAQ:ITCI) Cash Burn Situation

We can readily understand why investors are attracted to unprofitable companies. For example, although software-as-a-service business Salesforce.com lost money for years while it grew recurring revenue, if you held shares since 2005, you’d have done very well indeed. But while the successes are well known, investors should not ignore the very many unprofitable companies that

Read More